托克索普拉斯马脑炎是什么?

Same author

Letter: possible association between PPI use and spontaneous bacterial peritonitis.

Alimentary pharmacology & therapeutics·2015

Same author

PPI vs. teprenone in preventing recurrence of ulcers during low-dose aspirin.

Alimentary pharmacology & therapeutics·2014

Same author

Editorial: healing of refractory reflux oesophagitis--an ongoing unmet clinical need; authors' reply.

Alimentary pharmacology & therapeutics·2014

Same author

Predictors of either rapid healing or refractory reflux oesophagitis during treatment with potent acid suppression.

Alimentary pharmacology & therapeutics·2014

Same author

Commentary: improving the use of gastroprotective agents among high-risk NSAID users.

Alimentary pharmacology & therapeutics·2013

Same author

Impact of persistent, frequent regurgitation on quality of life in heartburn responders treated with acid suppression: a multinational primary care study.

Alimentary pharmacology & therapeutics·2013

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026

Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026

相关实验视频

托克索普拉斯马脑炎是什么?

相关概念视频

Letter: possible association between PPI use and spontaneous bacterial peritonitis.

PPI vs. teprenone in preventing recurrence of ulcers during low-dose aspirin.

Editorial: healing of refractory reflux oesophagitis--an ongoing unmet clinical need; authors' reply.

Predictors of either rapid healing or refractory reflux oesophagitis during treatment with potent acid suppression.

Commentary: improving the use of gastroprotective agents among high-risk NSAID users.

Impact of persistent, frequent regurgitation on quality of life in heartburn responders treated with acid suppression: a multinational primary care study.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

相关实验视频

托克索普拉斯马脑炎是什么?

相关概念视频

相关文章

Letter: possible association between PPI use and spontaneous bacterial peritonitis.

PPI vs. teprenone in preventing recurrence of ulcers during low-dose aspirin.

Editorial: healing of refractory reflux oesophagitis--an ongoing unmet clinical need; authors' reply.

Predictors of either rapid healing or refractory reflux oesophagitis during treatment with potent acid suppression.

Commentary: improving the use of gastroprotective agents among high-risk NSAID users.

Impact of persistent, frequent regurgitation on quality of life in heartburn responders treated with acid suppression: a multinational primary care study.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.